Physician profile
Ryan Bird
NPI 1306945316
$819.79
in general payments reported to CMS, 2019-2025
11 companies · $73.32 in 2025
The $73.32 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.92 · 2020: $35.08 · 2021: $12.49 · 2022: $170 · 2023: $429 · 2024: $46.46 · 2025: $73.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $369.86 | 2022-2023 | Cook, Zenith |
| Abiomed | $144.87 | 2023 | Impella |
| Portola Pharmaceuticals, LLC | $89.00 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $39.02 | 2021-2025 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $38.08 | 2022 | |
| Janssen Pharmaceuticals, INC | $33.01 | 2024 | Xarelto |
| Abbvie INC. | $29.02 | 2023 | Vraylar |
| Inari Medical, INC. | $24.37 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $22.42 | 2025 | Flowtriever |
| Genentech USA, INC. | $16.69 | 2022 | |
| Gilead Sciences, INC. | $13.45 | 2024 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.